484 Impact of 4-weekly capecitabine plus paclitaxel (XP) combination therapy for metastatic breast cancer: a multicenter phase II trial (KBCSG-0609)

✍ Scribed by D. Yamamoto; T. Taguchi; N. Masuda; T. Nakayama; T. Nagata; M. Nomura; K. Yoshidome; H. Yoshino; J. Sakamoto; S. Noguchi

• Book ID: 119601490
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 49 KB
• Volume: 8
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(10)70505-x